BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36362023)

  • 21. Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes.
    Wang B; Cheng D; Ma D; Chen R; Li D; Zhao W; Fang C; Ji M
    Cell Commun Signal; 2024 Jan; 22(1):21. PubMed ID: 38195554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer.
    Fang C; Cheung MY; Chan RC; Poon IK; Lee C; To CC; Tsang JY; Li J; Tse GM
    Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A feed-forward loop based on aerobic glycolysis and TGF-β between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.
    Shen C; Liu J; Jiao W; Zhang X; Zhao X; Yang X; Wang Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12867-12880. PubMed ID: 37462772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.
    Dawoud MM; Abd El Samie Aiad H; Kasem NS; El Khouly EA; Al-Sharaky DR
    J Immunoassay Immunochem; 2024 May; ():1-20. PubMed ID: 38815282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral Abundance of M2-Macrophages is Associated With Unfavorable Prognosis and Markers of T-Cell Exhaustion in Small Cell Lung Cancer Patients.
    Klein S; Schulte A; Arolt C; Tolkach Y; Reinhardt HC; Buettner R; Quaas A
    Mod Pathol; 2023 Oct; 36(10):100272. PubMed ID: 37423586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
    Yaghoobi V; Moutafi M; Aung TN; Pelekanou V; Yaghoubi S; Blenman K; Ibrahim E; Vathiotis IA; Shafi S; Sharma A; O'Meara T; Fernandez AI; Pusztai L; Rimm DL
    Breast Cancer Res; 2021 Dec; 23(1):113. PubMed ID: 34906209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma.
    Laberiano-Fernandez C; Baldavira CM; Machado-Rugolo J; Tamegnon A; Pandurengan RK; Ab'Saber AM; Balancin ML; Takagaki TY; Nagai MA; Capelozzi VL; Parra ER
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis.
    Soliman AH; Youness RA; Sebak AA; Handoussa H
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103792. PubMed ID: 37689125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists.
    Broggi G; Angelico G; Farina J; Tinnirello G; Barresi V; Zanelli M; Palicelli A; Certo F; Barbagallo G; Magro G; Caltabiano R
    Pathol Res Pract; 2024 Feb; 254():155144. PubMed ID: 38277747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The specific viral composition in triple-negative breast cancer tissue shapes the specific tumor microenvironment characterized on pathological images.
    Gao X; Yang H; Chu Y; Zhang W; Wang Z; Ji L
    Microb Pathog; 2023 Nov; 184():106385. PubMed ID: 37813319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of CD8
    Jin Q; Jiang H; Yue N; Zhang L; Li C; Dong C; Zeng P; Yue L; Wu C
    Leuk Lymphoma; 2024 Apr; 65(4):472-480. PubMed ID: 38198635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Proteomics Analysis Reveals Wiskott-Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1.
    Hu L; Liu D; Zheng D; Lu J; Yuan X; Li Y; Shi F; Shi X; He QY; Li Q; Zhang CZ
    J Proteome Res; 2024 Jun; 23(6):2195-2205. PubMed ID: 38661673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sexual Dimorphism in Outcomes of Non-muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint.
    Chenard S; Jackson C; Vidotto T; Chen L; Hardy C; Jamaspishvilli T; Berman D; Siemens DR; Koti M
    Eur Urol Open Sci; 2021 Jul; 29():50-58. PubMed ID: 34337534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal B Lymphocytes Affecting Prognosis in Triple-Negative Breast Cancer by Opal/TSA Multiplexed Immunofluorescence.
    Fang M; Yin W; Qiu C; Song T; Lin B; Wang Y; Xiong H; Wu S
    Int J Womens Health; 2024; 16():755-767. PubMed ID: 38706691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD47 expression and tumor-associated immune cells in breast cancer and their correlation with molecular subtypes and prognostic factors.
    Celepli P; Karabulut S; Bigat İ; Celepli S; Hücümenoğlu S
    Pathol Res Pract; 2022 Oct; 238():154107. PubMed ID: 36088827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization.
    Ben-Chetrit N; Niu X; Sotelo J; Swett AD; Rajasekhar VK; Jiao MS; Stewart CM; Bhardwaj P; Kottapalli S; Ganesan S; Loyher PL; Potenski C; Hannuna A; Brown KA; Iyengar NM; Giri DD; Lowe SW; Healey JH; Geissmann F; Sagi I; Joyce JA; Landau DA
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of Stromal and Serum Markers in Gastric Cancer.
    Kovaleva OV; Podlesnaya PA; Chang VL; Ognerubov NA; Gratchev AN; Kozlov NA; Stilidi IS; Kushlinskii NE
    Acta Naturae; 2022; 14(4):75-83. PubMed ID: 36694901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma.
    Rahimi Koshkaki H; Minasi S; Ugolini A; Trevisi G; Napoletano C; Zizzari IG; Gessi M; Giangaspero F; Mangiola A; Nuti M; Buttarelli FR; Rughetti A
    J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32899203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery.
    Giraldo NA; Berry S; Becht E; Ates D; Schenk KM; Engle EL; Green B; Nguyen P; Soni A; Stein JE; Succaria F; Ogurtsova A; Xu H; Gottardo R; Anders RA; Lipson EJ; Danilova L; Baras AS; Taube JM
    Cancer Immunol Res; 2021 Nov; 9(11):1262-1269. PubMed ID: 34433588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial heterogeneity of tumor cells and the tissue microenvironment in oral squamous cell carcinoma.
    Steffen C; Schallenberg S; Dernbach G; Dielmann A; Dragomir MP; Schweiger-Eisbacher C; Klauschen F; Horst D; Tinhofer I; Heiland M; Keilholz U
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; 137(4):379-390. PubMed ID: 38281880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.